2005
DOI: 10.1111/j.1398-9995.2005.00836.x
|View full text |Cite
|
Sign up to set email alerts
|

Aspirin‐triggered 15‐HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin‐Sensitive Patients Identification Test (ASPITest)*

Abstract: Our data demonstrate that ASA-induced 15-HETE generation by PBL is a specific and sensitive aspirin-sensitive patients identification test (ASPITest).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
49
0
4

Year Published

2006
2006
2016
2016

Publication Types

Select...
5
5

Relationship

2
8

Authors

Journals

citations
Cited by 83 publications
(54 citation statements)
references
References 37 publications
(38 reference statements)
1
49
0
4
Order By: Relevance
“…In Europe and Asia, the lysine-aspirin bronchoprovocation test is widely used, but these provocation tests are time-consuming and could produce severe asthmatic reactions, putting both patients and doctors at risk. Several studies have attempted to develop an in vitro diagnostic test for AIA, and it was reported that the level of aspirin-induced 15-hydroxyeicosatetranoic acid (15-HETE) in peripheral blood might be a specific in vitro test for identifying aspirin-sensitive patients (ASPI test); however, the test lacks sensitivity and requires complicated procedures, and the methodology has not been well standardized [28]. Although we need further validation studies in other populations, this SNP set based on a multilocus genetic interaction could be used as an in vitro test for predicting the risk of AIA.…”
Section: Discussionmentioning
confidence: 99%
“…In Europe and Asia, the lysine-aspirin bronchoprovocation test is widely used, but these provocation tests are time-consuming and could produce severe asthmatic reactions, putting both patients and doctors at risk. Several studies have attempted to develop an in vitro diagnostic test for AIA, and it was reported that the level of aspirin-induced 15-hydroxyeicosatetranoic acid (15-HETE) in peripheral blood might be a specific in vitro test for identifying aspirin-sensitive patients (ASPI test); however, the test lacks sensitivity and requires complicated procedures, and the methodology has not been well standardized [28]. Although we need further validation studies in other populations, this SNP set based on a multilocus genetic interaction could be used as an in vitro test for predicting the risk of AIA.…”
Section: Discussionmentioning
confidence: 99%
“…In about 10% of adult patients with asthma, aspirin and other NSAIDs that inhibit cyclooxygenase (COX) enzymes (COX-1 and COX-2) precipitate asthma attacks and naso-ocular reactions (148). This distinct clinical syndrome, called aspirin-induced asthma, is characterized by a typical sequence of symptoms: an intense eosinophilic inflammation of the nasal and bronchial tissues combined with an overproduction of cysteinyl leukotrienes (CysLT; 149) and other prostanoids (150,151). After the ingestion of aspirin or other NSAIDs, an acute asthma attack occurs within 3 hours, usually accompanied by profuse rhinorrhoea, conjunctival injection, periorbital edema and sometimes a scarlet flushing of the head and neck.…”
Section: Drug-induced Rhinitismentioning
confidence: 99%
“…Based on this observation, measurement of 15-HETE release from PBL has been proposed as Aspirin Sensitive Patient Identification Test (ASPITest Ò ) (38). Clinical usefulness of this test has not yet been confirmed by larger studies.…”
Section: -Hete Generation Assay (Aspitest)mentioning
confidence: 99%